| 000 | 02647 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250517145850.0 | ||
| 264 | 0 | _c20170728 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2016.70.7091 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScott, Bart L | |
| 245 | 0 | 0 |
_aMyeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 2017 |
||
| 300 |
_a1154-1161 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBusulfan _xadministration & dosage |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xtherapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPasquini, Marcelo C | |
| 700 | 1 | _aLogan, Brent R | |
| 700 | 1 | _aWu, Juan | |
| 700 | 1 | _aDevine, Steven M | |
| 700 | 1 | _aPorter, David L | |
| 700 | 1 | _aMaziarz, Richard T | |
| 700 | 1 | _aWarlick, Erica D | |
| 700 | 1 | _aFernandez, Hugo F | |
| 700 | 1 | _aAlyea, Edwin P | |
| 700 | 1 | _aHamadani, Mehdi | |
| 700 | 1 | _aBashey, Asad | |
| 700 | 1 | _aGiralt, Sergio | |
| 700 | 1 | _aGeller, Nancy L | |
| 700 | 1 | _aLeifer, Eric | |
| 700 | 1 | _aLe-Rademacher, Jennifer | |
| 700 | 1 | _aMendizabal, Adam M | |
| 700 | 1 | _aHorowitz, Mary M | |
| 700 | 1 | _aDeeg, H Joachim | |
| 700 | 1 | _aHorwitz, Mitchell E | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 35 _gno. 11 _gp. 1154-1161 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2016.70.7091 _zAvailable from publisher's website |
| 999 |
_c27052506 _d27052506 |
||